Exploring how the germinal center cellular program promotes efficient affinity maturation
In plain English
AI plain-English summaryEvery time a vaccine or infection triggers antibody production, B cells inside lymph nodes enter microscopic training camps called germinal centres, where they mutate their antibody genes and compete for survival signals. This fellowship tackles a basic mechanical puzzle inside those cells: how does a B cell rapidly swap out its old antibody receptor for a new, improved version, and how does it ensure that selection rewards only the newest specificity, not the old one it just discarded? The problem matters because the entire quality control system for antibody production depends on this handover happening correctly. If old receptors linger, cells could be selected based on outdated information, producing antibodies that bind poorly to the pathogen. The researcher will build genetic tools to tag and track receptors and MHCII proteins in real time, testing whether antigen presentation is deliberately suppressed during receptor replacement and favoured at other stages. This is fundamental science. It will not produce a vaccine or drug tomorrow. But understanding how germinal centres enforce fidelity in antibody selection could eventually reveal why some vaccines fail to generate long-lasting, high-affinity antibodies, and point toward ways to improve immunisation strategies.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Sir Henry Dale FellowshipPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know